EZH2 and breast cancer: Furthermore, EZH2 expression is an independent predictor of BC recurrence with its levels steadily increasing from the normal epithelium to epithelial hyperplasia, DCIS, IDC, and distant metastasis (Ding and Kleer, 2006).